T. Rowe Price Associates’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History

T. Rowe Price Associates’s Portfolio TVRD Stock Details TVRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-290	Closed	-$10K	–	3051
2024 Q1	$10K	Hold	290	–	–	﹤0.01%	2944
2023 Q4	$8K	Hold	290	–	–	﹤0.01%	2890
2023 Q3	$18K	Buy	+290	New	+$18K	﹤0.01%	2853
2021 Q4	–	Sell	-28,842	Closed	-$16M	–	3043
2021 Q3	$16M	Sell	28,842 -255	-0.9%	-$142K	﹤0.01%	1349
2021 Q2	$14.9M	Sell	29,097 -34,772	-54%	-$17.9M	﹤0.01%	1365
2021 Q1	$49.9M	Sell	63,869 -3,610	-5%	-$2.82M	0.01%	1002
2020 Q4	$36.8M	Sell	67,479 -20,799	-24%	-$11.3M	﹤0.01%	1054
2020 Q3	$40.4M	Sell	88,278 -14,383	-14%	-$6.59M	﹤0.01%	944
2020 Q2	$63.2M	Sell	102,661 -4,711	-4%	-$2.9M	0.01%	774
2020 Q1	$51.1M	Sell	107,372 -22,090	-17%	-$10.5M	0.01%	778
2019 Q4	$75.1M	Buy	129,462 +661	+0.5%	+$383K	0.01%	764
2019 Q3	$84.8M	Buy	128,801 +51,014	+66%	+$33.6M	0.01%	674
2019 Q2	$60.2M	Buy	77,787 +7,409	+11%	+$5.73M	0.01%	811
2019 Q1	$49.7M	Buy	70,378 +3,281	+5%	+$2.32M	0.01%	881
2018 Q4	$31.4M	Sell	67,097 -48	-0.1%	-$22.5K	0.01%	988
2018 Q3	$57.9M	Buy	67,145 +54,030	+412%	+$46.6M	0.01%	860
2018 Q2	$9.04M	Sell	13,115 -198	-1%	-$136K	﹤0.01%	1363
2018 Q1	$5.93M	Buy	13,313 +2	+0%	+$891	﹤0.01%	1408
2017 Q4	$5.87M	Buy	13,311 +637	+5%	+$281K	﹤0.01%	1398
2017 Q3	$6.25M	Sell	12,674 -452	-3%	-$223K	﹤0.01%	1391
2017 Q2	$7.27M	Buy	13,126 +5,035	+62%	+$2.79M	﹤0.01%	1363
2017 Q1	$5.36M	Buy	+8,091	New	+$5.36M	﹤0.01%	1423
2015 Q2	–	Sell	-7,045	Closed	-$2.55M	–	2558
2015 Q1	$2.55M	Hold	7,045	–	–	﹤0.01%	1550
2014 Q4	$2.53M	Sell	7,045 -7	-0.1%	-$2.51K	﹤0.01%	1543
2014 Q3	$2.13M	Buy	7,052 +6,763	+2,340%	+$2.04M	﹤0.01%	1569
2014 Q2	$177K	Sell	289 -4,034	-93%	-$2.47M	﹤0.01%	2378
2014 Q1	$2.9M	Buy	+4,323	New	+$2.9M	﹤0.01%	1503